Derek Lowe – Page 9
-
Opinion
Column: In the pipeline
Derek Lowe discusses the problem of leaning too heavily on favourite reactions
-
Opinion
Column: In the pipeline
Derek Lowe considers what makes a good looking drug molecule - and how beauty is in the eye of the beholder
-
Opinion
Column: In the pipeline
Derek Lowe wonders about pharmaceutical companies' motives for collaboration
-
Opinion
Column: In the pipeline
Derek Lowe considers what we think we know about how drugs work once we've taken them
-
Opinion
Column: In the pipeline
Derek Lowe considers the problems of addressing drug development out of sequence
-
Opinion
Column: In the pipeline
Derek Lowe worries that mergers are upsetting the balance of the pharmaceutical ecosystem
-
Opinion
Column: In the pipeline
How important is it to have the best equipped lab, wonders Derek Lowe
-
Opinion
Column: In the pipeline
Derek Lowe remembers leaving the ivory towers of academe to trade 'unusual and beautiful' for 'useful'
-
Opinion
Column: In the pipeline
Derek Lowe dreams of the day when chemists and biologists can understand each other
-
Opinion
Column: In the pipeline
Derek Lowe wonders what lessons we can learn from the Vytorin fiasco
-
Opinion
Column: In the pipeline
The recent row over antidepressants reminds us how little we know about the brain, says Derek Lowe